• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » 2005 Index

2005 Index

December 1, 2005
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Index to Volume 3, 2005 (issue:page)



  • Abilify, 2:2,4

  • Adderall, 4:4-6

  • ADHD, 4:1-8

  • Agitation in dementia, 8:4-5

  • Alcoholism, 9:4-6

  • Alzheimer’s disease, 8:1

  • Ambien, 9:2

  • Antidepressant augmentation, 1:5

  • Aricept, 8:2

  • Atypical antipsychotics, 2:1-8,8:6

  • Benzodiazepines, 9:1-8

  • Body Mass Index, 5:4

  • Bipolar depression, 6:1

  • Cholinesterase inhibitors, 8:1

  • Clozaril, 2:1

  • CME Bias, 3:1

  • Concerta, 4:2-3

  • Conflict of Interest, 3:4-5

  • Cymbalta, 1:1

  • Depakote in women, 10:4-5

  • Dexatrim, 5:6

  • Dexedrine, 4:2-3

  • Diabetes and atypicals, 2:1

  • Drug Industry Influence, 3:1-8

  • ECT, 1:1

  • Effexor, 1:1

  • Equetro, 6:1

  • Focalin, 4:2-3

  • Genetics and psychiatry, 11:1-8

  • Genetic counseling, 11:1

  • Generic antidepressants, 1:6

  • Geodon, 2:1,4

  • HIPAA, 7:4-6

  • Hypnotics, 9:1

  • Indiplon, 9:2

  • Insomnia, 9:1

  • Lab monitoring, 6:6

  • Lamictal, 6:4-5,10:4

  • Lexapro, 1:5

  • Lunesta, 9:1

  • “Mars and Venus”: 12:4-5

  • Meridia, 5:6

  • Metabolic Side Effects, 2:1,5:4-5

  • Namenda, 8:1

  • Nicotine Replacement, 5:3

  • Nortriptyline, 5:3

  • P450 genotyping, 11:1

  • Paxil, 10:3

  • Postpartum depression, 10:1

  • Pregnancy, 10:1-8

  • Progress note, 7:1

  • Psychostimulants, 4:1-3

  • Psychotherapy for ADHD, 4:1

  • QT prolongation, 2:4

  • Rating scales, 7:1

  • Risperdal, 2:1

  • Ritalin, 4:2

  • Rozerem, 9:1

  • Schizophrenia, 5:4-5

  • Seroquel, 2:1

  • Self-Help books, 12:1-8

  • Serzone, 1:6

  • Smoking Cessation, 5:1

  • SOAP note, 7:2

  • Sonata, 9:2

  • SSRIs in pregnancy, 10:1

  • Strattera, 4:3

  • Tegretol, 6:2

  • Thyroid augmentation, 1:5

  • Topamax, 10:5

  • Transcranial Magnetic Simulation, 1:1

  • Vagus nerve stimulation, 1:6

  • Weight loss, 5:1

  • Xenical, 5:6

  • Zyban, 5:3

  • Zyprexa, 2:1


Articles in Volume 3, 2005


January: Antidepressant Roundup 2005

  • The Dual Reuptake Wars

  • rTMS: Will It Replace ECT?

  • Antidepressant Updates: Generics, VNS, & Serzone

  • Michael J. Gitlin on Using the Newer Antidepressants


February: Atypical Antipsychotics 2005

  • Metabolic Side Effects: Here We Go Again!

  • Clozapine: Is it Truly Better Than the Rest?

  • Atypicals for Bipolar: And Then There Were Five

  • Philip G. Janicak, on Using Atypical Antipsychotics


March: Drug Industry Influence in Psychiatry

  • How to Sniff Out Bias in CME Programs

  • Journal Articles as Marketing: Tricks of the Trade

  • CME Bias: ACCME to the Rescue!

  • Jerome P. Kassirer, on Conflict of Interest in Medicine


April: Treating ADHD

  • Psychostimulants and Strattera Explained

  • Therapy vs. Meds for ADHD: Lessons from the MTA Study

  • Adderall and Death: It’s Team FDA vs. Team Canada!

  • Lawrence H. Diller, on The Use of Stimulants in ADHD


May: Weight Loss and Smoking Cessation in Psychiatry

  • How to Help Your Patients Lose Weight

  • Smoking Cessation: An Update

  • Laurence Guttmacher on Medical Screening in Schizophrenia


June: The Treatment of Bipolar Disorder

  • Equetro: New Name, Old Drug

  • Antidepressants in Bipolar Disorder: The Controversy Continues

  • Lab Monitoring with Mood Stabilizers: Let’s Get Real

  • Ivan Goldberg on Treating Bipolar Depression


July: Chart Documentation in Psychiatry

  • The Humble Progress Note

  • Using Psychiatric Rating Scales in Clinical Practice

  • HIPAA Compliance for Psychiatrists: A One-Stop Shop

  • Rebecca Brendel on HIPAA and Psychiatric Practice


August: Geriatric Psychiatry Update

  • Cholinesterase Inhibitors: Under Siege

  • Namenda: Pining for Another Indication

  • Rosack’s FDA Watch: Atypical Antipsychotics and the Elderly

  • Marc Agronin on Treating Agitation in Dementia


September: Benzodiazepines and Hypnotics in Psychiatry

  • Lunesta, Rozerem, and More: It’s Showtime for the New Hypnotics

  • Getting Patients off Benzos: Tips from Old Masters

  • Should We Prescribe Benzos to Alcohol Abusers?

  • John Talmadge on Using Benzodiazepines


October: Pregnancy and Psychiatric Treatment

  • Antidepressants and Pregnancy: Now What Should We Tell Our Patients?

  • Treating Postpartum Depression: A Look at the Evidence

  • Victoria Hendrick on Drug Interactions and Side Effects Specific to Women


November: Genetics and Psychiatry

  • P450 Genotyping: Ready for Prime Time?

  • Genetic Counseling: A Primer for Psychiatrists

  • Samuel H. Barondes on Genetic Research in Psychiatry


December: Self-Help Books in Psychiatry

  • TCR’s Top Self-Help Books in Psychiatry

  • 2005 Index

  • John Gray on The Essence of Mars and Venus

General Psychiatry
    www.thecarlatreport.com
    Issue Date: December 1, 2005
    SUBSCRIBE NOW
    Table Of Contents
    More Excellent Books for your Patients
    John Gray, Ph.D., on The Essence of Mars and Venus
    2005 Index
    TCR’s Top Self-Help Books in Psychiatry
    DOWNLOAD NOW
    Featured Book
    • MFB6eCover.jpg

      Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)

      Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
      READ MORE
    Featured Video
    • therapist_canstockphoto9201097.jpg
      General Psychiatry

      Using SAMe In Clinical Practice with Garrett Rossi, MD

      Read More
    Featured Podcast
    • canstockphoto22709844.jpg
      General Psychiatry

      Psychopharm Commandment #10: Don’t Fear these Meds

      Surprising health benefits of our riskiest meds: Lithium, quetiapine, and clozapine.

      Listen now
    Recommended
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png
    • Approaches to Autism Intervention

      January 31, 2022
      canstockphoto2240982_child-bubbles_thumb.jpg
    • Currently Available Cannabis Products

      September 1, 2022
    • Interpreting Assessment Discrepancies from Multiple Sources

      October 17, 2022
      ChildAssessment.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report

    Contact

    info@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.